A 76-year-old man with metastatic prostate cancer was referred to 68Ga prostate-specific
membrane antigen (PSMA) positron emission tomography/computed tomography (PET/CT) …

Abstract 68 Ga-labeled prostate-specific membrane antigen (PSMA) ligand PET/CT is a
rapidly evolving imaging modality for prostate cancer. However, with the widespread use of …

A 69-year-old man with a known history of gastric and prostate adenocarcinoma was
referred to 68 Ga–prostate-specific membrane antigen (PSMA) PET/CT for restaging due to …

Prostate cancer is the most common cancer in men. 68 Ga-PSMA PET/CT is frequently used
in staging and restaging prostate cancer; it is important to keep in mind the causes of false …

Abstract 68 Ga-PSMA PET/CT is increasingly used to assess prostate cancer. Avid 68 Ga-
PSMA uptake by thyroid cancer and renal cell carcinoma (RCC) has been reported in few …

Prostate-specific membrane antigen PET imaging has revolutionized the role of prostate
cancer diagnosis and management, with very high sensitivity and specificity. To prevent …

Abstract 68 Ga-PSMA PET/CT imaging is an emerging imaging modality in prostate cancer.
PSMA expression is also reported for nonprostate malignancies, including primary …

An 84-year-old man with prostate adenocarcinoma underwent 68 Ga-PSMA PET/CT due to
PSA recurrence. Foci of 68 Ga-PSMA uptake were observed in bilateral adrenal glands …

Abstract 68 Ga–prostate-specific membrane antigen (PSMA) PET/CT imaging is a relatively
new imaging technique used to evaluate the extent of disease in prostate carcinoma …

A 67-year-old man with prostate adenocarcinoma underwent 68 Ga-labeled prostate-
specific membrane antigen (PSMA) ligand PET/CT for restaging due to a rising prostate …